Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Amylyx Pharmaceuticals, Inc. See All Filings	D	2020-07-01 10:57:05 UTC
Amount To Be Raised $30,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-20-000002 Exclusions or Exemptions 506b Accepted Date 2020-07-01 10:57:05 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Amylyx Pharmaceuticals, Inc. See All Filings	D/A	2020-01-28 16:51:19 UTC
Amount To Be Raised $20,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-20-000001 Exclusions or Exemptions 506b Accepted Date 2020-01-28 16:51:19 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D/A	2019-12-31 11:20:46 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-19-000003 Exclusions or Exemptions 506b Accepted Date 2019-12-31 11:20:46 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D	2019-12-31 10:21:59 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-19-000001 Exclusions or Exemptions 506b Accepted Date 2019-12-31 10:21:59 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D	2018-11-20 12:04:30 UTC
Amount To Be Raised $12,978,100 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-18-000001 Exclusions or Exemptions 506b Accepted Date 2018-11-20 12:04:30 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D	2017-08-04 12:43:33 UTC
Amount To Be Raised $2,342,698 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-08-04 12:43:33 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D/A	2016-08-22 10:23:34 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-16-000004 Exclusions or Exemptions 506b Accepted Date 2016-08-22 10:23:34 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Amylyx Pharmaceuticals, Inc. See All Filings	D	2016-08-22 10:01:10 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-16-000003 Exclusions or Exemptions 506b Accepted Date 2016-08-22 10:01:10 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity
Amylyx Pharmaceuticals, Inc. See All Filings	D/A	2015-11-20 00:00:00 UTC
Amount To Be Raised $1,630,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-15-000002 Exclusions or Exemptions 506c Accepted Date 2015-11-20 00:00:00 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Debt
Amylyx Pharmaceuticals, Inc. See All Filings	D	2015-11-17 00:00:00 UTC
Amount To Be Raised $1,630,000 Associated Brokers / Dealers N/A CIK Number 0001658551 Filed Document 0001658551-15-000001 Exclusions or Exemptions 506c Accepted Date 2015-11-17 00:00:00 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business MASSACHUSETTS Revenue or Assets Decline to Disclose Type of Security Equity